coumarin has been researched along with Myocardial Infarction in 67 studies
2H-chromen-2-one: coumarin derivative
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "At coronary angiography <48 hours after fibrinolytic therapy, 308 patients receiving aspirin and intravenous heparin had a patent infarct-related artery (Thrombolysis In Myocardial Infarction [TIMI] grade 3 flow)." | 9.10 | Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. ( Aengevaeren, WR; Brouwer, MA; Hertzberger, DP; Luijten, HE; Uijen, GJ; van Boven, AJ; van den Bergh, PJ; Veen, G; Verheugt, FW; Vromans, RP, 2002) |
| " The present study was designed to investigate the cardioprotective effects of a newly synthesised coumarin, symbolised as 5,6-PhSHC, against cardiac remodelling process in isoproterenol (ISO) induced myocardial infarction (MI) in male Wistar rats by evaluating haematological, biochemical and cardiac biomarkers." | 8.12 | A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes ( Abid, M; Abid, S; Allouche, N; Ammar, H; Baaziz, I; Elmufti, A; Feriani, A; Ghazouani, L; Hajji, R; Khdhiri, E; Mnafgui, K; Ramazani, A; Tlili, N; Zarei, A, 2022) |
| "Patients with thrombolysis in myocardial infarction (TIMI) 3 flow <48 hours after fibrinolysis for ST-elevation myocardial infarction were randomized to aspirin plus coumarin, with prolonged heparinization until the target international normalized ratio (2-3) was reached, or aspirin with standard heparinization." | 5.14 | Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome. ( Aengevaeren, WR; Brouwer, MA; Kievit, PC; van den Bergh, PJ; Veen, G; Verheugt, FW, 2009) |
| "At coronary angiography <48 hours after fibrinolytic therapy, 308 patients receiving aspirin and intravenous heparin had a patent infarct-related artery (Thrombolysis In Myocardial Infarction [TIMI] grade 3 flow)." | 5.10 | Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. ( Aengevaeren, WR; Brouwer, MA; Hertzberger, DP; Luijten, HE; Uijen, GJ; van Boven, AJ; van den Bergh, PJ; Veen, G; Verheugt, FW; Vromans, RP, 2002) |
| " The present study was designed to investigate the cardioprotective effects of a newly synthesised coumarin, symbolised as 5,6-PhSHC, against cardiac remodelling process in isoproterenol (ISO) induced myocardial infarction (MI) in male Wistar rats by evaluating haematological, biochemical and cardiac biomarkers." | 4.12 | A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes ( Abid, M; Abid, S; Allouche, N; Ammar, H; Baaziz, I; Elmufti, A; Feriani, A; Ghazouani, L; Hajji, R; Khdhiri, E; Mnafgui, K; Ramazani, A; Tlili, N; Zarei, A, 2022) |
| "Anticoagulant treatment with coumarins is due to it unequivocal benefit and relatively low risk increasingly used for prevention of sudden cerebrovascular attacks, in atrial fibrillation, in the treatment of thromboembolic disease, as part of treatment after replacement of cardiac valves and other diseases." | 3.70 | [Retroperitoneal hematoma and femoral compression neuropathy--a complication of anticoagulation therapy after myocardial infarct]. ( Gonsorcík, J; Jonás, P; Jurgová, T; Kristian, P; Kucinský, R; Lazúr, J; Tokarcíková, A; Tomasch, J, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 59 (88.06) | 18.7374 |
| 1990's | 1 (1.49) | 18.2507 |
| 2000's | 5 (7.46) | 29.6817 |
| 2010's | 1 (1.49) | 24.3611 |
| 2020's | 1 (1.49) | 2.80 |
| Authors | Studies |
|---|---|
| Ghazouani, L | 1 |
| Khdhiri, E | 1 |
| Elmufti, A | 1 |
| Zarei, A | 1 |
| Feriani, A | 1 |
| Baaziz, I | 1 |
| Hajji, R | 1 |
| Abid, M | 1 |
| Ammar, H | 1 |
| Abid, S | 1 |
| Allouche, N | 1 |
| Mnafgui, K | 1 |
| Ramazani, A | 1 |
| Tlili, N | 1 |
| Kemkes-Matthes, B | 1 |
| van den Bergh, PJ | 2 |
| Kievit, PC | 1 |
| Brouwer, MA | 2 |
| Aengevaeren, WR | 2 |
| Veen, G | 2 |
| Verheugt, FW | 2 |
| PARKER, RL | 1 |
| BARKER, NW | 1 |
| WRIGHT, IS | 2 |
| NICHOL, ES | 1 |
| PAGE, SW | 1 |
| Wijnen, PA | 1 |
| Verschakelen, JA | 1 |
| Bast, A | 1 |
| Bekers, O | 1 |
| Drent, M | 1 |
| Luijten, HE | 1 |
| Hertzberger, DP | 1 |
| van Boven, AJ | 1 |
| Vromans, RP | 1 |
| Uijen, GJ | 1 |
| LOSSE, H | 1 |
| BEAUMONT, JL | 1 |
| MAURICE, P | 1 |
| CHEVALIER, H | 1 |
| COBLENTZ, B | 1 |
| LENEGRE, J | 1 |
| RUSSEK, HI | 2 |
| ZOHMAN, BL | 2 |
| DOERNER, AA | 2 |
| RUSSEK, AS | 2 |
| WHITE, LG | 2 |
| BOLT, RJ | 1 |
| ZILOVA, AN | 1 |
| LAKSHINA, LK | 1 |
| DELLA SANTA, R | 1 |
| RICHTER, IH | 2 |
| SWILLER, SL | 2 |
| DEL NUNZIO, RF | 1 |
| ROSE, OA | 1 |
| OTT, RH | 1 |
| MAIER, HC | 1 |
| ABRAMOV, AL | 1 |
| KALLNER, G | 1 |
| PREZIOSI, P | 1 |
| KOLLER, F | 1 |
| JAKOB, H | 1 |
| HOLLER, G | 1 |
| WEINMANN, O | 1 |
| HAMMERL, H | 1 |
| ZEMANN, J | 1 |
| COOGAN, TJ | 1 |
| DAVIS, JA | 1 |
| PETERSEN, ES | 1 |
| RAEVSKAIA, GA | 1 |
| LACHAINE, G | 1 |
| MANTERO, O | 1 |
| RANDAZZO, A | 1 |
| KUSHELEVSKII, BP | 1 |
| IASAKOVA, OI | 1 |
| EFIMOVA, GM | 1 |
| LUTHY, F | 1 |
| DEUTSCH, E | 4 |
| HUEBER, EF | 1 |
| MAYER, E | 1 |
| WOHLRAB, K | 1 |
| TUDHOPE, GR | 1 |
| DONALD, AC | 1 |
| FELDMAN, L | 1 |
| SCHAEFER, GL | 1 |
| GOLDSTEIN, SE | 1 |
| FORMAN, IM | 1 |
| MANCHESTER, B | 1 |
| RABKIN, B | 1 |
| SCHMIDT-ELMENDORFF, H | 1 |
| HEICHMANN, J | 1 |
| CLOWARD, RB | 1 |
| YUHL, ET | 1 |
| BRUNTON, L | 1 |
| LOWENSTEIN, L | 1 |
| SHAPIRO, L | 1 |
| MANSON, DI | 1 |
| FULLERTON, HW | 1 |
| CORDEIRO, A | 1 |
| CRESPO, FF | 1 |
| MURI, JW | 1 |
| PARTILLA, H | 1 |
| STOCKINGER, L | 1 |
| ROSENTHAL, RL | 3 |
| RONCALLO, E | 1 |
| BOGGERO, C | 1 |
| HUNTER, GA | 2 |
| LANDER, H | 2 |
| KAISER, E | 1 |
| LEEB, H | 1 |
| MULLER, K | 1 |
| BAER, S | 1 |
| YARROW, MW | 1 |
| KRAVITZ, C | 1 |
| MARKSON, V | 1 |
| BENDA, L | 1 |
| ZISCHKA, W | 1 |
| DILLON, MT | 1 |
| REILLY, EB | 1 |
| GOODMAN, JR | 1 |
| WARNER, GF | 1 |
| FAIVRE, G | 1 |
| GILGENKRANTZ, JM | 1 |
| CHERRIER, F | 1 |
| TENETTE, C | 1 |
| BARRUCAND, D | 1 |
| GARB, S | 1 |
| HERLES, F | 1 |
| JAROSOVA, V | 1 |
| HOEPKER, W | 1 |
| BECHER, K | 1 |
| SMITH, KS | 1 |
| PAPP, C | 1 |
| SHAPIRO, S | 2 |
| GORINSHTEIN, ML | 1 |
| KASATKIN, EV | 1 |
| MERKUL', VE | 1 |
| FIL'KOVA, EM | 1 |
| MENDEZ, L | 1 |
| ZAJARIAS, S | 1 |
| DELGADO, A | 1 |
| DEL NUNZIO, R | 1 |
| SYNER, JC | 1 |
| WEAVER, JC | 1 |
| BENEDEK, A | 1 |
| LOPES CARDOZO, E | 1 |
| MOLENAAR, M | 1 |
| Kristian, P | 1 |
| Kucinský, R | 1 |
| Gonsorcík, J | 1 |
| Jonás, P | 1 |
| Tokarcíková, A | 1 |
| Lazúr, J | 1 |
| Jurgová, T | 1 |
| Tomasch, J | 1 |
| Fitzgerald, PJ | 1 |
| Oshima, A | 1 |
| Hayase, M | 1 |
| Metz, JA | 1 |
| Bailey, SR | 1 |
| Baim, DS | 1 |
| Cleman, MW | 1 |
| Diver, DJ | 1 |
| Leon, MB | 1 |
| Moses, JW | 1 |
| Oesterle, SN | 1 |
| Overlie, PA | 1 |
| Pepine, CJ | 1 |
| Safian, RD | 1 |
| Shani, J | 1 |
| Simonton, CA | 1 |
| Smalling, RW | 1 |
| Teirstein, PS | 1 |
| Zidar, JP | 1 |
| Yeung, AC | 1 |
| Kuntz, RE | 1 |
| Yock, PG | 1 |
| Hirsh, J | 1 |
| Dalen, J | 1 |
| Anderson, DR | 1 |
| Poller, L | 1 |
| Bussey, H | 1 |
| Ansell, J | 1 |
| Deykin, D | 1 |
| Kühnel, L | 1 |
| Karge, M | 1 |
| Heinrichs, C | 1 |
| Stigge, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gemini Angioplasty and Arterial Measurement Evaluation (GAAME) An Evaluation of the Metricath Gemini System, a Percutaneous Interventional Device Intended to Make Arterial Lumen Measurements and Perform Percutaneous Transluminal Angioplasty Dilations.[NCT00399646] | Phase 2 | 145 participants (Actual) | Interventional | 2005-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for coumarin and Myocardial Infarction
| Article | Year |
|---|---|
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Coumarins; Drug Interactions; Food; Heart | 2001 |
3 trials available for coumarin and Myocardial Infarction
| Article | Year |
|---|---|
Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
Topics: Aged; Anticoagulants; Aspirin; Coronary Occlusion; Coumarins; Hemorrhage; Humans; International Norm | 2009 |
Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
Topics: Anticoagulants; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Disease-Free Survival; D | 2002 |
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Coronary Vessels; Coumarins; Female; Fibrinolytic A | 2000 |
63 other studies available for coumarin and Myocardial Infarction
| Article | Year |
|---|---|
A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes
Topics: Animals; Antioxidants; Body Weight; Cardiotonic Agents; Catalase; Coumarins; Electrocardiography; Gl | 2022 |
[Anticoagulation by oral treatment with vitamin K antagonists].
Topics: Administration, Oral; Anticoagulants; Arrhythmias, Cardiac; Coumarins; Drug Interactions; Humans; In | 2008 |
The use of anticoagulants in the management of acute myocardial infarction; a preliminary report.
Topics: Anticoagulants; Blood Coagulation; Coronary Vessels; Coumarins; Heart; Heparin; Humans; Infarction; | 1947 |
Experiences with dicumarol (3,3' methylene-bis-[4-hydroxycoumarin]) in the treatment of coronary thrombosis with myocardial infarction; preliminary report.
Topics: 4-Hydroxycoumarins; Coronary Thrombosis; Coumarins; Dicumarol; Heart; Humans; Infarction; Myocardial | 1946 |
Dicumarol therapy in acute coronary thombosis; results in fifty attacks; with review of data on embolic complications and immediate mortality in myocardial infarction.
Topics: Coronary Thrombosis; Coumarins; Dicumarol; Embolism; Heart; Humans; Infarction; Myocardial Infarctio | 1946 |
Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Coumarins; Female; Hemorrhage; | 2013 |
[Therapy of fresh myocardial infarction with anticoagulants].
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Myocardial Infarction | 1952 |
[Anticoagulant therapy of myocardial infarct; in vitro heparin tolerance test].
Topics: Anticoagulants; Coumarins; Heparin; Humans; In Vitro Techniques; Myocardial Infarction | 1952 |
Indications for dicumarol in acute myocardial infarction.
Topics: Acute Disease; Anterior Wall Myocardial Infarction; Cardiovascular Diseases; Coumarins; Dicumarol; M | 1951 |
Myocardial infarction; comparison of results following use of dicumarol and dicumarol with heparin in the acute stage.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Heparin; Myocardial Infarction | 1953 |
[Application of dicoumarin in myocardial infarctions and in thromboses of peripheral vessels].
Topics: Coumarins; Dicumarol; Humans; Myocardial Infarction; Thrombosis | 1953 |
[The treatment of myocardial infarction by dicumarol and its derivatives (tromexan); its biological control].
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Ethyl Biscoumacetate; Myocardial Infarction | 1952 |
A study of the sedimentation rate in cases of myocardial infarction under dicumarol therapy.
Topics: Blood Sedimentation; Cardiovascular Diseases; Coumarins; Dicumarol; Hematologic Tests; Myocardial In | 1952 |
Hemopericardium with tamponade during anticoagulant therapy of myocardial infarct; report of a case with recovery following pericardiotomy.
Topics: Anticoagulants; Coumarins; Hemorrhage; Myocardial Infarction; Pericardial Effusion; Pericardiectomy; | 1953 |
Dicumarol and myocardial infarction.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Myocardial Infarction | 1953 |
[Therapy of myocardial infarct].
Topics: Adenosine Triphosphate; Ascorbic Acid; Bile Acids and Salts; Coumarins; Diet; Folic Acid; Heparin; H | 1953 |
[A new highly active anticoagulant with prolonged effect (marcoumar)].
Topics: Anticoagulants; Coumarins; Heparin Antagonists; Humans; Infarction; Lung; Myocardial Infarction; Phe | 1953 |
[Heparin tolerance test and prothrombin time in the control of anticoagulant therapy of coronary infarction].
Topics: Anticoagulants; Coumarins; Heparin; Humans; Infarction; Myocardial Infarction; Prothrombin Time | 1953 |
Experiences with the long range use of anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Myocardial Infarction; Thromboembolism | 1953 |
[Dicoumarin therapy of myocardial infarct].
Topics: Coumarins; Dicumarol; Myocardial Infarction | 1953 |
[A strange accident due to anticoagulant medication].
Topics: Accidents; Anticoagulants; Coumarins; Hematoma; Hemorrhage; Humans; Myocardial Infarction; Thigh | 1953 |
[Treatment of myocardial infarct with anticoagulants].
Topics: Anticoagulants; Coumarins; Heparin; Humans; Myocardial Infarction | 1953 |
[Therapy of myocardial infarct with dicumarin].
Topics: Coumarins; Myocardial Infarction | 1953 |
[Arteritis nodosa; findings in a case].
Topics: Coumarins; Disease; Humans; Muscles; Muscular Diseases; Myocardial Infarction; Polyarteritis Nodosa | 1954 |
[The therapeutic use of a new anticoagulant, marcoumar].
Topics: Anticoagulants; Coumarins; Myocardial Infarction; Phenprocoumon; Thromboembolism; Thrombophlebitis | 1954 |
Late results of treatment in myocardial infarction; effect of short-term anticoagulant therapy on the mortality at one year.
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Heparin; Humans; Myocardial Infarction | 1954 |
Bishydroxycoumarin (dicumarol) therapy in myocardial infarction; results of bishydroxycoumarin therapy as it is practiced in a private hospital.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Hospitals, Private; Myocardial Infarction | 1954 |
The control of dicumarol therapy in myocardial infarction by a simple blood prothrombin test.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Hemostatics; Myocardial Infarction; Prothrombin; Prot | 1954 |
[Anticoagulants in myocardial infarct after coronary thrombosis].
Topics: Anticoagulants; Coronary Disease; Coronary Thrombosis; Coumarins; Humans; Myocardial Infarction | 1954 |
[Anticoagulant treatment in myocardial infarction].
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Myocardial Infarction | 1955 |
Spontaneous intraspinal hemorrhage and paraplegia complicating dicumarol therapy.
Topics: Coumarins; Dicumarol; Hemorrhage; Humans; Myocardial Infarction; Paraplegia; Spinal Cord | 1955 |
Some experience with the anticoagulant cyclocumarol.
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Myocardial Infarction; Thrombosis | 1955 |
Present status of anticoagulant therapy in the treatment of myocardial infarction; the use and misuse of anticoagulants; an evaluation of new anticoagulants, their indications and dosage.
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Heparin; Humans; Myocardial Infarction; Phenindi | 1955 |
Anticoagulant therapy in cardiac infarction.
Topics: Anticoagulants; Coumarins; Heparin; Humans; Infarction; Myocardial Infarction | 1956 |
[Anticoagulant therapy of myocardial infarct].
Topics: Anticoagulants; Coumarins; Humans; Myocardial Infarction | 1955 |
Long-term treatment with dicumarol in myocardial infarction.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Humans; Long-Term Care; Myocardial Infarction | 1956 |
[Dicumarol: its properties and mode of action. II. Fibroblast culture in the course of a myocardial infarct].
Topics: Coumarins; Dicumarol; Fibroblasts; Immunologic Tests; Myocardial Infarction; Research Design; Tissue | 1956 |
Over-all coagulability in patients receiving dicumarol therapy with emphasis on acute myocardial infarction.
Topics: Blood Coagulation; Cardiovascular Diseases; Coagulants; Coumarins; Dicumarol; Humans; Myocardial Inf | 1956 |
[A new coumarin derivative in the treatment of myocardial infarct].
Topics: Coumarins; Humans; Myocardial Infarction | 1956 |
A new coumarin derivative (G23350): a preliminary study.
Topics: Coumarins; Myocardial Infarction | 1956 |
A new coumarin derivative (G23350): a preliminary study.
Topics: Coumarins; Myocardial Infarction | 1956 |
A new coumarin derivative (G23350): a preliminary study.
Topics: Coumarins; Myocardial Infarction | 1956 |
A new coumarin derivative (G23350): a preliminary study.
Topics: Coumarins; Myocardial Infarction | 1956 |
[Sintrom, a new short-term anticoagulant monocoumarin derivative].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Myocardial Infarction; Thrombosis | 1957 |
[Prevention of complications during therapy of thromboses and myocardial infarct with anticoagulants (heparin, coumarin) by successful administration of butazolidin].
Topics: Anticoagulants; Coumarins; Embolism; Heparin; Humans; Myocardial Infarction; Phenylbutazone; Thrombo | 1957 |
Clinical experiences with warfarin (coumadin) sodium as an anticoagulant.
Topics: Anticoagulants; Coronary Disease; Coumarins; Dicumarol; Humans; Myocardial Infarction; Sodium; Warfa | 1958 |
[Problems of anticoagulant treatment].
Topics: Anticoagulants; Coumarins; Heparin; Myocardial Infarction | 1958 |
Cerebellar ischemia as a complication of myocardial infarction during treatment with acenocoumarin.
Topics: Acenocoumarol; Cardiovascular Diseases; Cerebellum; Coumarins; Myocardial Infarction | 1959 |
COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
Topics: Anticoagulants; Blood Coagulation Tests; Coumarins; Dicumarol; Factor VII; Geriatrics; Hemostatics; | 1963 |
[CRITICAL STUDY, BASED ON 43 CASES, OF A COUMARIN ANTICOAGULANT: DICOUMOXYL (1-METHOXY-2,2-BIS-(4-HYDROXY-3-COU- MARINYL)-ETHANE)].
Topics: Anticoagulants; Arrhythmias, Cardiac; Coronary Disease; Coumarins; Ethane; Mitral Valve Stenosis; My | 1963 |
The current status of anticoagulants in the treatment of myocardial infarction.
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Heparin; Humans; Myocardial Infarction | 1955 |
[Hazards and indications for pelentan therapy of myocardial infarction].
Topics: Cardiovascular Diseases; Coumarins; Ethyl Biscoumacetate; Myocardial Infarction | 1952 |
[Results of prolonged coumarin therapy after heart infarct].
Topics: Coumarins; Humans; Myocardial Infarction | 1959 |
The prevention of impending cardiac infarction by anticoagulant treatment.
Topics: Angina, Unstable; Anticoagulants; Coronary Disease; Coumarins; Heparin; Humans; Infarction; Myocardi | 1951 |
Oral anticoagulant therapy in myocardial infarction.
Topics: Anticoagulants; Coronary Disease; Coumarins; Myocardial Infarction | 1951 |
[Treatment with dicoumarin of myocardial infarction; preliminary communication].
Topics: Coronary Disease; Coumarins; Dicumarol; Humans; Myocardial Infarction | 1952 |
[Anticoagulants in the treatment of myocardial infarction].
Topics: Anticoagulants; Coronary Disease; Coumarins; Myocardial Infarction | 1951 |
Indications for bishydroxycoumarin (dicumarol) in acute myocardial infarction.
Topics: Anterior Wall Myocardial Infarction; Coumarins; Dicumarol; Myocardial Infarction | 1952 |
An evaluation of the dicumarol therapy in 300 cases of myocardial infarction.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Myocardial Infarction | 1952 |
Extensive pericarditis complicating myocardial infarction.
Topics: Cardiovascular Diseases; Coumarins; Humans; Myocardial Infarction; Pericarditis | 1952 |
Acceleration of blood coagulation in acute myocardial infarction as demonstrated by the heparin clotting time; effect of dicumarol therapy.
Topics: Blood Coagulation; Coumarins; Dicumarol; Heparin; Humans; Myocardial Infarction | 1952 |
Anticoagulant therapy in myocardial infarction.
Topics: Anticoagulants; Coumarins; Myocardial Infarction | 1952 |
Studies on blood coagulation in acute myocardial infarction.
Topics: Blood Coagulation; Coumarins; Humans; Myocardial Infarction | 1952 |
[Prolonged dicumarol therapy of severe angina pectoris and recurrent heart infarct].
Topics: Angina Pectoris; Coumarins; Dicumarol; Humans; Myocardial Infarction | 1952 |
[Retroperitoneal hematoma and femoral compression neuropathy--a complication of anticoagulation therapy after myocardial infarct].
Topics: Anticoagulants; Atrial Fibrillation; Cerebrovascular Disorders; Coumarins; Female; Hematoma; Hemorrh | 1998 |
Investigations of antithrombin III-activity in patients after myocardial infarction and a long-term coumarin therapy.
Topics: Aged; Antithrombin III; Coumarins; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Fa | 1988 |